No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Diagnostics & Research
FALCO HOLDINGS Co., Ltd., a medical services enterprise established in 1962 and headquartered in Kyoto, Japan, primarily delivers clinical diagnostic testing and pharmaceutical dispensing solutions. The company serves medical institutions and various corporations throughout Japan. Its comprehensive range of clinical testing encompasses specialized areas such as genetics, biochemistry, hematology, pathology, immunology, microbiology, and radioimmunoassay. Beyond direct diagnostics, FALCO HOLDINGS also engages in genomic-based drug discovery and the development of biotechnological pharmaceuticals. The company's offerings extend to medical information technology services, as well as environmental and food sanitation testing. They also provide genetic testing tailored for the food industry, catering to manufacturers, retailers, and restaurants. Additionally, FALCO HOLDINGS operates dispensing pharmacies and drugstores. They are also active in the development and sale of medical information systems, notably including "@home Dr.," an electronic medical record system designed for clinics with a high volume of clinical testing, and "TASCAL for ASP," a robust medical support system.
www.falco-hd.co.jpNo one on the platform currently holds 4671.T.
No tracked institution reports a position in 4671.T as of their last filing.
No one on the platform has traded 4671.T yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 9.2% | 11.7% | 9.8% | — | — | — |
| Rev. Growth % | 0.6% | -0.0% | ||||
| Profit Margin % | 4.6% | 5.0% | 4.0% | |||
| Free Cash Flow Margin % | 3.5% | 3.5% | 2.6% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2027 | $43.6B | +0.9% | $182.70 | $182.70–$182.70 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 4671.TFALCO HOLDINGS Co., Ltd. | $2885.00 | +0.98% | $28.9B | — |
| 2374.TSaint-Care Holding Corporation | $1212.00 | +0.00% | $29.9B | — |
| 2929.TPharma Foods International Co., Ltd. | $712.00 | +3.04% | $20.7B | — |
| 3154.TMedius Holdings Co., Ltd. | $777.00 | +1.57% | $17.3B | — |
| 3417.TOhki Healthcare Holdings Co.,Ltd. | $1003.00 | +0.30% | $13.7B | — |
| 3649.TFINDEX Inc. | $915.00 | +4.57% | $22.3B | — |
| 3939.TKanamic Network Co.,LTD | $490.00 | -0.61% | $23.3B | — |
Source: Financial Modeling Prep · peers by sector/industry